$AEPP The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA. http://smallcapvoice.com/blog/9-12-17-smallcapvoice-interview-with-oncolix-inc-aepp/